Impax Laboratories, Inc.
IPXL
IPXL was delisted on the 4th of May, 2018.
196 hedge funds and large institutions have $2.84B invested in Impax Laboratories, Inc. in 2015 Q4 according to their latest regulatory filings, with 36 funds opening new positions, 71 increasing their positions, 67 reducing their positions, and 34 closing their positions.
18% more capital invested
Capital invested by funds: $2.4B → $2.84B (+$440M)
7% more call options, than puts
Call options by funds: $3.36M | Put options by funds: $3.14M
6% more repeat investments, than reductions
Existing positions increased: 71 | Existing positions reduced: 67
6% more first-time investments, than exits
New positions opened: 36 | Existing positions closed: 34
1% more funds holding
Funds holding: 195 → 196 (+1)
14% less funds holding in top 10
Funds holding in top 10: 7 → 6 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Alyeska Investment Group
Chicago,
Illinois
|
+$18.6M |
| 2 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$16.3M |
| 3 |
Invesco
Atlanta,
Georgia
|
+$15.5M |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$15.1M |
| 5 |
Millennium Management
New York
|
+$12.3M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Franklin Resources
San Mateo,
California
|
-$34.5M |
| 2 |
PCM
Pennant Capital Management
Summit,
New Jersey
|
-$28.8M |
| 3 |
SPC
Slate Path Capital
New York
|
-$25.9M |
| 4 |
SCA
Southpoint Capital Advisors
New York
|
-$24.6M |
| 5 |
HCM
Hayman Capital Management
Dallas,
Texas
|
-$21.4M |
IPXL Hedge Fund Activity: Q4 2015 in Review
196 of the 3,813 institutional investors tracked by Wall St. Rank reported a position in Impax Laboratories, Inc. (IPXL) for Q4 2015, worth a combined $2.84B — up 18% from $2.4B a quarter earlier.
Buyers outnumbered sellers: 36 funds opened new IPXL positions and 34 closed out — a net gain of 2 holders — while 71 added to existing stakes and 67 trimmed.
The largest buyer was Alyeska Investment Group, adding an estimated $18.6M. The largest seller was Franklin Resources, cutting an estimated $34.5M.
- 196 institutional investors held Impax Laboratories, Inc. (IPXL) as of Q4 2015, up from 195 in Q3 2015.
- Funds reported $2.84B of Impax Laboratories, Inc. stock for Q4 2015, up 18% quarter-over-quarter.
- 36 funds opened new Impax Laboratories, Inc. positions in Q4 2015 and 34 closed out, a net change of +2 holders.
- The largest Impax Laboratories, Inc. buyer in Q4 2015 was Alyeska Investment Group, an estimated $18.6M added.
- The largest Impax Laboratories, Inc. seller in Q4 2015 was Franklin Resources, an estimated $34.5M sold.
Based on aggregated 13F filings for Q4 2015.